# Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia

Study · id `cardio:ct-nct03906539` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03906539](<https://clinicaltrials.gov/study/NCT03906539>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03906539

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

## Technical summary

Registry record NCT03906539. Randomized; double masking; primary purpose treatment. Start 2019-05-22 (actual); primary completion 2021-11-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT03906539, source copy `cardio:ctgov-nct03906539-2022-04-06`, retrieved 2026-10-31)
- Started: 2019-05-22 (actual) (ClinicalTrials.gov record NCT03906539, source copy `cardio:ctgov-nct03906539-2022-04-06`, retrieved 2026-10-31)
- Primary completion: 2021-11-30 (actual) (ClinicalTrials.gov record NCT03906539, source copy `cardio:ctgov-nct03906539-2022-04-06`, retrieved 2026-10-31)
- Completion: 2021-12-31 (actual) (ClinicalTrials.gov record NCT03906539, source copy `cardio:ctgov-nct03906539-2022-04-06`, retrieved 2026-10-31)
- Countries: India (ClinicalTrials.gov record NCT03906539, source copy `cardio:ctgov-nct03906539-2022-04-06`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03906539-2022-04-06`, retrieved 2026-10-31)

## The registry's words

- Brief title: Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia
- Condition: Dyslipidemias
- Intervention (Drug): Atorvastatin 10mg
- Intervention (Dietary supplement): Virgin Coconut Oil (VCO)
- Intervention (Other): Placebo
- Lead sponsor: All India Institute of Medical Sciences, Bhubaneswar
- Lead sponsor class: OTHER
- Collaborator: Coconut Development Board, Government of India
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry lists this organization as the lead sponsor: All India Institute of Medical Sciences, Bhubaneswar (`cardio:org-all-india-institute-of-medical-sciences-bhubaneswar`)

## Provenance

Content hash: 96524e73a2a8faba6ef4adf215b2438fa8db40d71950461c7c7e6cafa589e34c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
